Search the Newsreel

Sotera Health (SHC): Sessa Capital discloses 27M-share, 9.5% ownership position

Sessa Capital IM, L.P. and John Petry have disclosed a beneficial ownership of 27,050,000 shares of Sotera Health Co (SHC) common stock, representing a 9.5% stake. This information was reported on an amended Schedule 13G filing, indicating shared voting and dispositive power over these …

ASP Isotopes (NASDAQ:ASPI) Posts Quarterly Earnings Results, Misses Expectations By $0.11 EPS

ASP Isotopes (NASDAQ:ASPI) reported a quarterly loss of $0.28 per share, missing analysts' consensus estimate by $0.11. The company exhibited a negative net margin of 644.40% and a negative return on equity of 112.46%. Following the earnings release, ASPI shares fell 0.2% to $4.27, …

ASP Isotopes (ASPI) grows revenue to $9.3M while burning cash to expand

ASPI: Quarterly revenue grew to $5.1M, net loss narrowed, and Renergen acquisition expanded operations

ASPI's quarterly revenue increased to $5.1 million due to acquisitions and new segments, while its net loss from continuing operations narrowed to $34.0 million. The company completed the Renergen acquisition, diversifying into helium and LNG, and improved its liquidity, though it faces integration, regulatory, …

Sotera Health (SHC): Sculptor Capital discloses 24M-share, 8.41% ownership stake

Sculptor Capital LP and its related entities have reported a beneficial ownership stake of 8.41% in Sotera Health Company (SHC), totaling 24,000,000 common shares. This disclosure, made via an amended Schedule 13G filing, indicates shared voting and dispositive power over these shares. The ownership …

Sotera Health announces resignation of director James C. Neary

Sotera Health (NASDAQ:SHC) announced the resignation of James C. Neary from its Board of Directors, effective Thursday. The company clarified that his resignation was not due to any disagreements regarding its operations. This news follows Sotera Health's strong second-quarter financial results, where it surpassed …

China Isotope & Radiation Sets Board Meeting to Approve Interim Results and Consider Dividend

Sotera Health Company (SHC): Buy, Sell, or Hold Post Q2 Earnings?

Sotera Health Company (SHC) has gained 11.3% over the last six months, slightly underperforming the S&P 500. Analysts are not recommending SHC due to slow organic growth, limited distribution channels for a small company in a scale-dependent industry, and breakeven free cash flow constraining …

Sotera Health (SHC) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Jason Peterson Executive Chairman - Michael Petras Chief Executive Officer - Alton Shader Chief Financial Officer - Jonathan Lyons Full Conference Call …

ASPI Stock Back In Focus Amid Race For Non-Russian HALEU Supply — Retail Points To Semiconductor Chip Opportunity

President of Sterigenics U.S. Of Sotera Health Sold 37% Of Their Shares

The President of Sterigenics U.S., Michael Rutz, recently sold 37% of his shares in Sotera Health Company (NASDAQ:SHC) for approximately US$2.8 million. This sale follows another significant insider sale by the Executive Chairman of the Board, Michael Petras, worth US$12 million over the past …

Sotera Health Company’s Q2 Earnings Call: Our Top 5 Analyst Questions

Sotera Health reported strong Q2 2026 results with broad-based growth across its business units, exceeding analyst estimates for revenue, EPS, and EBITDA, and subsequently raising its full-year guidance. The article highlights five key analyst questions from the earnings call, focusing on drivers of Nelson …

Insider Transaction: Michael Rutz Sells $2.83M Worth Of Sotera Health Shares

ASP Isotopes Targets 2026 Deliveries as Helium, Radiopharmacy Expansion Gains Speed

ASP Isotopes (ASPI) plans to expand its isotope production, radiopharmacy, and helium businesses, targeting commercial deliveries of stable isotopes by the second half of 2026. The company is developing proprietary enrichment technologies and expects its Renergen platform to begin Phase 1 helium production by …

Southern Energy Corp. Announces Spudding of Cotton Valley Test Well at Williamsburg and Appointment of Market Maker

CALGARY, AB / ACCESS Newswire / August 12, 2026 / Southern Energy Corp. ("Southern" or the "Company") (TSXV:SOU)(AIM:SOUC), an established producer with natural gas and light oil assets in Mississippi, announces that, further to the announcement of the Joint Venture Wellbore Participation Agreement with …

Sotera Health (NASDAQ:SHC) Insider Sells $2,826,000.00 in Stock

Sotera Health insider Michael Rutz sold 150,000 shares of the company's stock for $2,826,000.00, reducing his position by nearly 31%. This sale follows strong quarterly results where the company beat EPS estimates and saw revenue increase by 9.2% year-over-year. Analysts have maintained a "Moderate …

Earnings Call Transkript: Southern Cross Media legt gemischte Ergebnisse für H2 2026 vor

Sotera Health Company (SHC) Reported Positive Results Amid Litigation Wins

US-based investment company McIntyre Partnerships delivered flat performance in H1 2026, returning 0% gross and -1% net compared to the Russell 2000 Value Index's 23% return. A copy of the letter can be downloaded here. The second quarter results were a complete reversal of …

Sotera Health (SHC) Is Getting Attention Again, What Is Behind It?

Sotera Health (SHC) has gained renewed attention following its Q2 2026 earnings, reporting increased revenue and net income. The stock has shown strong recent performance, with a 22.23% 90-day return and a 35.00% one-year return. Analysts have a consensus price target of $20.22, suggesting …

Sotera Health (SHC) Stock Trails Profit Surge As Legal Risks Linger

Sotera Health (SHC) recently reported strong Q2 2026 earnings, with significant increases in revenue and net income, yet its stock price barely moved due to lingering legal risks, heavy capital spending, and past insider selling. The company's operating performance, particularly in its sterilization and …

Southern (SO) Stock Stays Cheap On Earnings While Broader Checks Look Expensive

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Southern stock has delivered a 68.4% return over the past five years, yet its low value score suggests the current price of US$92.69 does …

ASP Isotopes Inc (ASPI) Earnings Forecast: Future EPS & Revenue Growth Estimates

Southern (SO) Completes Multiple Large Convertible Debt Offerings

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Southern Company (NYSE: SO) announces completion of several large senior unsecured convertible bond offerings. The new issues are structured as fixed income securities with conversion …

Piper Sandler Maintains Sotera Health Company(SHC.US) With Buy Rating, Raises Target Price to $25

Piper Sandler has reiterated its "Buy" rating for Sotera Health Company (SHC.US) and increased the target price to $25. This indicates a positive outlook from the analyst firm regarding the company's future performance.

Sotera Health (SHC) Is Up 5.9% After Q2 Earnings Beat And Guidance Hike What’s Changed

Sotera Health Company's Q2 2026 results, released on August 6, showed revenue rising to US$321.38 million and net income to US$53.64 million, with earnings per share from continuing operations increasing to US$0.19 from US$0.03 a year earlier. Management's decision to raise full-year guidance after …

ASP Isotopes Inc. Announces that Renergen Limited’s Subsidiary has Entered into a Take-or-Pay Contract for the Supply of Liquified Natural Gas to Be Produced at the Virginia Gas Project in South Africa

ASP Isotopes (NASDAQ: ASPI) announced that its subsidiary, Tetra4, has secured a five-year take-or-pay LNG sales contract with a South African food processor for its Virginia Gas Project. This agreement, priced at over $16 per GJ, covers approximately 10% of Phase 1 LNG capacity, …

GUIDANCE: (SHC) Sotera Health Expects Full Year 2026 Revenue Range $1.24B - $1.25B, Vs. FactSet Est of $1.24B

Sotera Health (SHC) has provided its revenue guidance for the full year 2026, expecting it to fall within the range of $1.24 billion to $1.25 billion. This forecast aligns closely with FactSet's estimated revenue of $1.24 billion for the same period. The guidance offers …

Sotera Health Company Stock 12‑Month Price Target Raised to $21.44, Implies 19% Upside

Sotera Health Company (SHC) has seen its average 12-month price target raised from $20.44 to $21.44 by analysts, implying a 19% potential upside based on its closing price on August 5th. The consensus rating among 10 analysts remains a "Buy," with 8 recommending Buy …

ASP Isotopes (ASPI) Projected to Announce Quarterly Earnings on Friday

ASP Isotopes (ASPI) is projected to announce its Q2 2026 earnings on Friday, August 14th, with analysts forecasting a loss of $0.17 per share and revenue of $4.47 million. The company reported a smaller loss and higher revenue than expected in the previous quarter. …

Sotera Health Co 2026: Revenue $321.38M, EPS $0.19— 10-Q Summary

Sotera Health Co (SHC) reported strong second-quarter 2026 results, with revenue reaching $321.38 million and diluted EPS of $0.19. The company saw significant year-over-year improvement across all key financial metrics, driven by higher service pricing and a favorable product mix. Despite ongoing expenses related …

Form 8K ASP Isotopes Inc For: 6 August By Investing.com

This article is a brief financial market announcement from Investing.com, stating that ASP Isotopes Inc. filed a Form 8K on August 6. It provides no further details about the filing itself, serving primarily as a news headline. The article also lists various market data …

Is Sotera Health Co (SHC) Overvalued After Q2 Earnings Beat? EPS at $0.19 vs. Est. $0.17; Revenue at $321.4M

Will Sotera Health's (SHC) Sharp Profit Rebound and Higher EPS Rewrite Its Turnaround Narrative?

Sotera Health (SHC) reported a significant profit rebound in Q2 2026, with net income rising to US$53.64 million and EPS to US$0.19, shifting from a net loss in the first half of the year. This turnaround in profitability is a key catalyst for its …